Category: Research

In 2012, Koning, then a doctoral student at the University of Wisconsin, Madison, began investigating the Ngao valley reserves to see how widespread and successful they truly were. Over the next eight years, he spent a total of 18 months living with communities across the region, where he documented around 50 different reserves. He selected 23 to study in depth, interviewing villagers and snorkeling the waters inside and outside the reserves to count and measure fish, along with study co-author Martin Perales.

That said, scientists at the University of Wisconsin-Madison have developed a battery-free implant that’s powered by stomach movements.

Much of the South’s early communications infrastructure was installed in the 1960s, expanded during the late 1980s and early 1990s, and remains in use today. According to industry experts and data from institutions like the University of Michigan and the University of Wisconsin, Madison, it is nearing the end of its life span. Without serious intervention by federal and state governments, these systems may not hold up to extreme weather events as they grow in intensity and frequency due to climate change.

The research was led by Fanny Moffette, a postdoctoral researcher in applied economics in the Nelson Institute for Environmental Studies and the Department of Agricultural and Applied Economics at the University of Wisconsin–Madison. Moffette collaborated with Jennifer Alix-Garcia at Oregon State University, Katherine Shea at the World Resources Institute, and Amy Pickens at the University of Maryland.

The news should be welcomed by the most hard-nosed of business people and economists as well. According to a recent news article published by the University of Wisconsin-Madison, the savings resulting from the reduction in carbon emissions range anywhere from $149 million to $696 million. These fiscal numbers are “based on the ability of lower emissions to reduce the detrimental economic consequences of climate change.”

A contactless thermometer is helping some UW-Madison students track COVID-19 symptoms, and the thermometer was designed and created on the university’s campus.

Enter Revive Therapeutics, a biotech company with its fingers in several pies: the emerging psychedelics industry, where it has a research partnership with the University of Wisconsin-Madison for formulation development and a clinical trial for substance use using psilocybin; the cannabis industry, where it has patented several unique cannabinoid delivery methods; and more recently, the market for coronavirus treatments, where it is one of fewer than 20 companies undertaking a phase 3 FDA trial—and the one with the lowest market cap.

The Journal of Nervous and Mental Disease flagged the article, “Observations on Homosexuality Among University Students,” which was written by UW professor Benjamin Glover. The study based itself on psychotherapy work and Glover’s belief that he could “cure” homosexual attraction.

MIT professor and physician Jeffry Harris utilized public health data with anonymized smartphone tracking data to reach his conclusion. Harris collected the smartphone data from late August through early October and compared it to COVID-19 cases from the 19 census tracts on and around UW-Madison’s campus.

A recent complaint against the Wisconsin National Primate Research Center (WNPRC) over mistreatment of animal research subjects at UW-Madison is just one item in a decades-long list of grievances animal rights groups have brought against the laboratory.

Fit Families, now based at the University of Wisconsin-Madison, started as an extension of Columna’s work in Guatemala for children with visual impairments, but now offers workshops for children with autism.

University researchers Thomas Friedrich and David O’Connor, and their labs, analyzed the spread of the coronavirus in a Nov. 3 study published in Nature Journal. The initial data indicated Dane and Milwaukee Counties had limited genetic mixing, with reduced rates of spread after Gov. Tony Evers’ Safer at Home executive order was implemented.

We now have the first data released from a third covid-19 vaccine, the one in trials here in Madison. The AstraZeneca vaccine seems to be the least effective of the three so far.

Known as Solvent-Targeted Recovery and Precipitation (STRAP) processing, the experimental technology is being developed by scientists at the University of Wisconsin-Madison.

UW Health is a part of the clinical trial for the drug. UW Health’s principal investigator for the Regeneron trial, Dr. William Hartman, said this authorization is a big step.

The Wisconsin Alumni Research Foundation (WARF) will pay a minimum of $32 million to a former research partner after it concealed information related to a patent for a kidney dialysis drug.

The Teaching and Learning International Survey (TALIS) — a video study in part conducted by a WCER director, looking into the practices and presentation of mathematics education approaches — has been recently acknowledged for its originality by the Paris branch of Organisation for Economic Cooperation and Development (OECD).

A new antifungal compound that is effective against even multidrug-resistant fungi has been found in the microbiome of a marine animal.Fungal infections affect hundreds of millions of people globally each year. “They’re particularly a problem for people whose immune system is suppressed,” says David Andes at the University of Wisconsin–Madison. This includes people being treated for cancer, organ transplant recipients and premature babies.

Researchers at the University of Wisconsin are taking part in a new study funded by the National Institute of Health examining the development of Alzheimer’s disease in people with Down syndrome.

Ruling found WARF ’systematically diluted the relative value’ of patent.

A team of UW-Madison engineers is back with another innovation to keep people safe during the pandemic. This fall, they designed the Badger Seal to be worn over a mask.

The “Badger Seal” prevents gaps on the sides, top & bottom of a face mask.

Through a newfound understanding of the way insulin secretion is triggered in pancreatic cells, scientists at the University of Wisconsin-Madison have uncovered an exciting new pathway for the development of treatments for type 2 diabetes. Not only does the discovery shine a light on how the cells work to keep blood sugar in check, the team was able to demonstrate how the mechanism could be targeted with a certain enzyme to hold it at healthy levels.